Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Stock indices serve as market barometers, benchmarks, and investment guides. Learn how they inform decisions and performance tracking.
17,462 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
A downgrade and AI chip headlines pushed Broadcom stock lower today. Here’s what happened, what it could mean, and pr...
AI-driven demand and memory shortages could propel Micron to new highs by late 2027. This article lays out why a big ...
Morgan Stanley labels Microsoft the most under-owned megacap as the stock slides this year. A $50 billion AI investme...
When NVIDIA reports earnings on Feb. 25, investors will scan every line for AI demand signals, margin trends, and gui...
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
The past year reshaped The Trade Desk in ways that matter to investors. This article breaks down what changed, why it...
Planet Labs delivered its first full year of profitability, with a ballooning backlog and AI partnerships driving a r...
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Microsoft’sAI push fuels cloud and enterprise gains even as capital outlays rise and OpenAI losses widen. Analysts ma...
Nvidia sits at the center of a fast-changing tech stack. This article breaks down how the company can reach higher st...
As travel demand rebounds, investors want clarity on which cruise stock to buy in 2026. This guide contrasts Royal Ca...